作者：
Firas,Fneish [1]
;
Niklas,Frahm [1]
;
Melanie,Peters [2]
;
David,Ellenberger [1]
;
Judith,Haas [3]
;
Micha,Löbermann [1]
;
Dieter,Pöhlau [4]
;
Anna-Lena,Röper [5]
;
Sarah,Schilling [4]
;
Alexander,Stahmann [1]
;
Herbert,Temmes [4]
;
Friedemann,Paul [1]
;
Uwe K,Zettl [1]
作者单位：
MS Forschungs- und Projektentwicklungs-gGmbH (MS Research and Project Development gGmbH [MSFP]), German MS Registry, 30171 Hannover, Germany.
[1]
Neuroimmunological Section, Department of Neurology, University Medical Center of Rostock, 18147 Rostock, Germany.
[2]
Gesellschaft für Versorgungsforschung mbH (Society for Health Care Research [GfV]), German MS Registry, 30171 Hannover, Germany.
[3]
Deutsche Multiple Sklerose Gesellschaft, Bundesverband e.V. (German MS Society Federal Association [DMSG]), 30171 Hannover, Germany.
[4]
Department of Tropical Medicine, Infectious Diseases and Nephrology, University Medical Center of Rostock, 18057 Rostock, Germany.
[5]
Experimental and Clinical Research Center, Joint Cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, The Charité Medical Faculty, Campus Berlin-Buch, 13125 Berlin, Germany.
[6]
Department of Neurology, Charité-Universitätsmedizin, 10117 Berlin, Germany.
[7]
NeuroCure Clinical Research Center, Charité-Universitätsmedizin, 10117 Berlin, Germany.
[8]
DOI
10.3390/vaccines11121859
PMID
38140262
发布时间
2023-12-25
换一批
换一批
